The emerging role of KCl cotransport in tumor biology

American Journal of Translational Research

Volumn 2, Issue 4, 2010, Pages 345-355

  Chen, Yih Fung ^a   Chou, Cheng Yang ^a   Clive Ellory, J ^b   Shen, Meng Ru ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cervical cancer; KCl cotransport; Metastasis; Migration; Ovarian cancer; Proliferation

Indexed keywords

BETA CATENIN; GELATINASE A; ISOPROTEIN; MUTANT PROTEIN; POTASSIUM CHLORIDE; POTASSIUM CHLORIDE COTRANSPORTER; SLC12A4 PROTEIN; SLC12A5 PROTEIN; SLC12A6 PROTEIN; SLC12A7 PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG; UVOMORULIN;

CANCER CELL; CANCER INHIBITION; CANCER INVASION; CANCER PATIENT; CARCINOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; DIFFERENTIAL DISPLAY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; LAMELLIPODIUM; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; OUTCOME ASSESSMENT; PELVIS LYMPH NODE; PREDICTION; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; TRANSCRIPTION REGULATION; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM;

EID: 77957326910     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Dunham PB, Stewart GW, Ellory JC. Chlorideactivated passive potassium transport in human erythrocytes. Proc Natl Acad Sci USA 1980; 77: 1711-1715.
2. Lauf PK. Evidence for chloride-dependent potassium and water transport induced by hyposmotic stress in erythrocytes of the marine teleost, Opsanus tau. J Comp Physiol 1982; 146: 9-16.
3. Lauf PK, Theg BE. A chloride dependent K+ flux induced by N-ethylmaleimide in genetically low K+ sheep and goat erythrocytes. Biochem Biophys Res Commun 1980; 92: 1422-1428.
4. Lauf PK, Adragna NC. K-Cl cotransport: properties and molecular mechanism. Cell Physiol Biochem 2000; 10: 341-354.
5. Gillen CM, Brill S, Payne JA, Forbush B 3rd. Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family. J Biol Chem 1996; 271: 16237-16244.
6. Payne JA, Stevenson TJ, Donaldson LF. Molecular characterization of a putative K-Cl cotransporter in rat brain. A neuronal-specific isoform. J Biol Chem 1996; 271: 16245-16252.
7. Hiki K, D'Andrea RJ, Furze J, Crawford J, Woollatt E, Sutherland GR, Vadas MA, Gamble JR. Cloning, characterization, and chromosomal location of a novel human K+-Cl-cotransporter. J Biol Chem 1999; 274: 10661-10667.
8. Mount DB, Mercado A, Song L, Xu J, George AL Jr, Delpire E, Gamba G. Cloning and characterization of KCC3 and KCC4, new members of the cation-chloride cotransporter gene family. J Biol Chem 1999; 274: 16355-16362.
9. Race JE, Makhlouf FN, Logue PJ, Wilson FH, Dunham PB, Holtzman EJ. Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter. Am J Physiol 1999; 277: C1210-C1219.
10. Adragna NC, Di Fulvio M, Lauf PK. Regulation of K-Cl cotransport: from function to genes. J Membr Biol 2004; 201: 109-137.
11. Mercado A, Song L, Vazquez N, Mount DB, Gamba G. Functional comparison of the K+-Cl-cotransporters KCC1 and KCC4. J Biol Chem 2000; 275: 30326-30334.
12. Payne JA. Functional characterization of the neuronal-specific K-Cl cotransporter: implications for [K+]o regulation. Am J Physiol 1997; 273: C1516-C1525.
13. Song L, Mercado A, Vázquez N, Xie Q, Desai R, George AL Jr, Gamba G, Mount DB. Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. Brain Res Mol Brain Res 2002; 103: 91-105.
14. Lauf PK, Bauer J, Adragna NC, Fujise H, Zade-Oppen AMM, Ryu KH, Delpire E. Erythrocyte K-Cl cotransport: properties and regulation. Am J Physiol 1992; 263: C917-C932.
15. Flatman PW, Adragna NC, Lauf PK. Role of protein kinases in regulating sheep erythrocyte K-Cl cotransport. Am J Physiol 1996; 271: C255-C263.
16. Jennings ML, al-Rohil N. Kinetics of activation and inactivation of swelling-stimulated K+/Cltransport. The volume-sensitive parameter is the rate constant for inactivation. J Gen Physiol 1990; 95: 1021-1040.
17. Kahle KT, Rinehart J, de Los Heros P, Louvi A, Meade P, Vazquez N, Hebert SC, Gamba G, Gimenez I, Lifton RP. WNK3 modulates transport of Cl-in and out of cells: implications for control of cell volume and neuronal excitability. Proc Natl Acad Sci U S A 2005; 102: 16783-16788.
18. Garzón-Muvdi T, Pacheco-Alvarez D, Gagnon KB, Vázquez N, Ponce-Coria J, Moreno E, Delpire E, Gamba G. WNK4 kinase is a negative regulator of K+-Cl-cotransporters. Am J Physiol Renal Physiol 2007; 292: F1197-F1207.
19. Rinehart J, Maksimova YD, Tanis JE, Stone KL, Hodson CA, Zhang J, Risinger M, Pan W, Wu D, Colangelo CM, Forbush B, Joiner CH, Gulcicek EE, Gallagher PG, Lifton RP. Sites of regulated phosphorylation that control K-Cl cotransporter activity. Cell 2009; 138: 525-536.
20. Holtzman EJ, Kumar S, Faaland CA, Warner F, Logue PJ, Erickson SJ, Ricken G, Waldman J, Kumar S, Dunham PB. Cloning, characterization, and gene organization of K-Cl cotransporter from pig and human kidney and C. elegans. Am J Physiol 1998; 275: F550-F564.
21. Su W, Shmukler BE, Chernova MN, Stuart-Tilley AK, de Franceschi L, Brugnara C, Alper SL. Mouse K-Cl cotransporter KCC1: cloning, mapping, pathological expression, and functional regulation. Am J Physiol 1999; 277: C899-C912.
22. Casula S, Shmukler BE, Wilhelm S, Stuart-Tilley AK, Su W, Chernova MN, Brugnara C, Alper SL. A dominant negative mutant of the KCC1 K-Cl cotransporter: both N-and C-terminal cytoplasmic domains are required for K-Cl cotransport activity. J Biol Chem 2001; 276: 41870-41878.
23. Shen MR, Chou CY, Hsu KF, Hsu YM, Chiu WT, Tang MJ, Alper SL, Ellory JC. KCl cotransport is an important modulator of human cervical cancer growth and invasion. J Biol Chem 2003; 278: 39941-39950.
24. Chen YF, Chou CY, Wilkins RJ, Ellory JC, Mount DB, Shen MR. Motor protein-dependent membrane trafficking of KCl cotransporter-4 is important for cancer cell invasion. Cancer Res 2009; 69: 8585-8593.
25. Brugnara C, Bunn HF, Tosteson DC. Regulation of erythrocyte cation and water content in sickle cell anemia. Science 1986; 232: 388-390.
26. Lew VL, Bookchin RM. Ion transport pathology in the mechanism of sickle cell dehydration. Physiol Rev 2005; 85: 179-200.
27. Joiner CH, Rettig RK, Jiang M, Risinger M, Franco RS. Urea stimulation of KCl cotransport induces abnormal volume reduction in sickle reticulocytes. Blood 2007; 109: 1728-1735.
28. Rust MB, Alper SL, Rudhard Y, Shmukler BE, Vicente R, Brugnara C, Trudel M, Jentsch TJ, Hübner CA. Disruption of erythroid K-Cl cotransporters alters erythrocyte volume and partially rescues erythrocyte dehydration in SAD mice. J Clin Invest 2007; 117: 1708-1717.
29. Sallinen R, Tornberg J, Putkiranta M, Horelli-Kuitunen N, Airaksinen MS, Wessman M. Chromosomal localization of SLC12A5/Slc12a5, the human and mouse genes for the neuron-specific K(+)-Cl(-) cotransporter (KCC2) defines a new region of conserved homology. Cytogenet Cell Genet 2001; 94: 67-70.
30. Strange K, Singer TD, Morrison R, Delpire E. Dependence of KCC2 K-Cl cotransporter activity on a conserved carboxy terminus tyrosine residue. Am J Physiol 2000; 279: C860-C867.
31. Hübner CA, Stein V, Hermans-Borgmeyer I, Meyer T, Ballanyi K, Jentsch TJ. Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron 2001; 30: 515-524.
32. Woo NS, Lu J, England R, McClellan R, Dufour S, Mount DB, Deutch AY, Lovinger DM, Delpire E. Hyperexcitability and epilepsy associated with disruption of the mouse neuronal-specific K-Cl cotransporter gene. Hippocampus 2002; 12: 258-268.
33. Li H, Khirug S, Cai C, Ludwig A, Blaesse P, Kolikova J, Afzalov R, Coleman SK, Lauri S, Airaksinen MS, Keinänen K, Khiroug L, Saarma M, Kaila K, Rivera C. KCC2 interacts with the dendritic cytoskeleton to promote spine development. Neuron 2007; 56: 1019-1033.
34. Howard HC, Mount DB, Rochefort D, Byun N, Dupre N, Lu J, Fan X, Song L, Riviere JB, Prevost C, Horst J, Simonati A, Lemcke B, Welch R, England R, Zhan FQ, Mercado A, Siesser WB, George AL Jr, McDonald MP, Bouchard JP, Mathieu J, Delpire E, Rouleau GA. The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet 2002; 32: 384-392.
35. Pearson MM, Lu J, Mount DB, Delpire E. Localization of the K+-Cl-cotransporter, KCC3, in the central and peripheral nervous systems: expression in the choroid plexus, large neurons and white matter tracts. Neuroscience 2001; 103: 481-491.
36. Shen MR, Chou CY, Hsu KF, Liu HS, Dunham PB, Holtzman EJ, Ellory JC. The KCl cotransporter isoform KCC3 can play an important role in cell growth regulation. Proc Natl Acad Sci U S A. 2001; 98: 14714-14719.
37. Zhang J, Lauf PK, Adragna NC. Platelet-derived growth factor regulates K-Cl cotransport in vascular smooth muscle cells. Am J Physiol 2003; 284: C674-C680.
38. Boettger T, Rust MB, Maier H, Seidenbecher T, Schweizer M, Keating DJ, Faulhaber J, Ehmke H, Pfeffer C, Scheel O, Lemcke B, Horst J, Leuwer R, Pape HC, Völkl H, Hübner CA, Jentsch TJ. Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. EMBO J 2003; 22: 5422-5434.
39. Rust MB, Faulhaber J, Budack MK, Pfeffer C, Maritzen T, Didié M, Beck FX, Boettger T, Schubert R, Ehmke H, Jentsch TJ, Hübner CA. Neurogenic mechanisms contribute to hypertension in mice with disruption of the K-Cl cotransporter KCC3. Circ Res 2006; 98: 549-556.
40. Byun N, Delpire E. Axonal and periaxonal swelling precede peripheral neurodegeneration in KCC3 knockout mice. Neurobiol Dis 2007; 28: 39-51.
41. Velazquez H, Silva T. Cloning and localization of KCC4 in rabbit kidney: expression in distal convoluted tubule. Am J Physiol 2003; 285: F49-F58.
42. Karadsheh MF, Byun N, Mount DB, Delpire E. Localization of the KCC4 potassium-chloride cotransporter in the nervous system. Neuroscience 2004; 123: 381-391.
43. Boettger T, Hübner CA, Maier H, Rust MB, Beck FX, Jentsch TJ. Deafness and renal tubular acidosis in mice lacking the K-Cl co-transporter Kcc4. Nature 2002; 416: 874-878.
44. Shen MR, Chou CY, Ellory JC. Volume-sensitive KCl cotransport associated with human cervical carcinogenesis. Pfluegers Arch 2000; 440: 751-760.
45. Fürstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002; 3: 298-302.
46. Shen MR, Hsu YM, Hsu KF, Chen YF, Tang MJ, Chou CY. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling. Carcinogenesis 2006; 27: 962-971.
47. Shen MR, Lin AC, Hsu YM, Chang TJ, Tang MJ, Alper SL, Ellory JC, Chou CY. Insulin-like growth factor 1 stimulates KCl cotransport, which is necessary for invasion and proliferation of cervical cancer and ovarian cancer cells. J Biol Chem 2004; 279: 40017-40025.
48. Hsu YM, Chou CY, Chen HH, Lee WY, Chen YF, Lin PW, Alper SL, Ellory JC, Shen MR. IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness. J Cell Physiol 2007; 210: 626-636.
49. Hsu YM, Chen YF, Chou CY, Tang MJ, Chen JH, Wilkins RJ, Ellory JC, Shen MR. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition. Cancer Res 2007; 67: 11064-11073.
50. Lee MY, Chou CY, Tang MJ, Shen MR. Epithelialmesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail upregulation. Clin Cancer Res 2008; 14: 4743-4750.
51. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-981.
52. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142.
53. Aznavorian S, Murphy AN, Stetler-Stevenson WG Liotta LA. Molecular aspects of tumour cell invasion and metastasis. Cancer 1993; 71: 1368-1383.
54. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346-1353.
55. Brand FX, Ravanel N, Gauchez AS, Pasquier D, Payan R, Fagret D, Mousseau M. Prospect for anti-HER2 receptor therapy in breast cancer. Anticancer Res 2006; 26: 463-470.
56. Christofori G. New signals from the invasive front. Nature 2006; 441: 444-450.
57. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.